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ed November 26, 2013.he purpose of this study was to investigate the role of plasminogen (Plg) in stem cell–mediated cardiac repair and
regeneration after myocardial infarction (MI).Background An MI induces irreversible tissue damage, eventually leading to heart failure. Bone marrow (BM)–derived stem cells
promote tissue repair and regeneration after MI. Thrombolytic treatment with Plg activators signiﬁcantly improves
the clinical outcome in MI by restoring cardiac perfusion. However, the role of Plg in stem cell–mediated cardiac
repair remains unclear.Methods An MI was induced in Plg-deﬁcient (Plg/) and wild-type (Plgþ/þ) mice by ligation of the left anterior descending
coronary artery. Stem cells were visualized by in vivo tracking of green ﬂuorescent protein (GFP)-expressing BM cells
after BM transplantation. Cardiac function, stem cell homing, and signaling pathways downstream of Plg were
examined.Results Granulocyte colony-stimulating factor, a stem cell mobilizer, signiﬁcantly promoted BM-derived stem cell
(GFPþc-kitþ cell) recruitment into the infarcted heart and stem cell–mediated cardiac repair in Plgþ/þ mice.
However, Plg deﬁciency markedly inhibited stem cell homing and cardiac repair, suggesting that Plg is critical
for stem cell–mediated cardiac repair. Moreover, Plg regulated C-X-C chemokine receptor type 4 (CXCR4)
expression in stem cells in vivo and in vitro through matrix metalloproteinase-9. Lentiviral reconstitution of
CXCR4 expression in BM cells successfully rescued stem cell homing to the infarcted heart in Plg-deﬁcient mice,
indicating that CXCR4 has a critical role in Plg-mediated stem cell homing after MI.Conclusions These ﬁndings have identiﬁed a novel role for Plg in stem cell–mediated cardiac repair after MI. Thus, targeting Plg
may offer a new therapeutic strategy for stem cell–mediated cardiac repair after MI. (J Am Coll Cardiol
2014;63:2862–72) ª 2014 by the American College of Cardiology FoundationIschemic heart disease, including myocardial infarction
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bolytic therapy and primary angioplasty, have signiﬁcantly
decreased early mortality of patients with MI. However,
continuous overloads in the surviving myocardium eventu-
ally leads to heart failure. Epidemiological data have shown
that about 60% of heart failure results from ischemic heart
disease (1). Standard therapy for heart failure that addressesSee page 2873the fundamental problem of cardiomyocytes loss is cardiac
transplantation, but this treatment has limited application
because of insufﬁcient donor hearts and the need for long-
term immunosuppressive therapy. New discoveries on the
regenerative potential of stem cells for preventing heart
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2863failure have transformed experimental research and led to an
explosion in clinical investigation (2–6).
Stem cell homing to the heart to promote cardiac repair
and regeneration after MI is a naturally occurring process.
However, it occurs too slowly, and recruited stem cells are
not sufﬁcient to be meaningful for the recovery of heart
function (7). To reach the efﬁcient regeneration of damaged
myocardium, therapeutic treatments have been developed
by transplantation of a large number of stem cells in-
to the bloodstream or infarcted heart or enhanced mobili-
zation of stem cells from bone marrow by treatments with
cytokines, such as granulocyte colony-stimulating factor
(G-CSF) (8,9). However, insufﬁcient stem cell engraftment
and survival during these treatments have limited the
application of stem cell therapy for treating MI (10,11).
Therefore, a better understanding of the underlying
mechanisms regulating stem cell function during cardiac
repair may lead to the development of novel approaches for
stem cell therapies.
Plasminogen (Plg) is the main enzyme responsible for
ﬁbrinolysis. The Plg system contains a proenzyme, Plg,
which is converted to the active enzyme plasmin by tissue
Plg activator or urokinase Plg activator (12). As a throm-
bolytic agent, tissue Plg activator (tPA) has been utilized
as the ﬁrst line of treatment of acute MI for almost 2 de-
cades. In addition to its canonical function, Plg is critical for
cardiac repair after MI, wound healing, and liver injury
(13–15). However, the mechanism for Plg-regulated cardiac
repair remains largely unknown.
In this study, using a knockout mouse model, stem cell
tracking and genetic lentiviral approaches, and an experi-
mental MI model, we have elucidated a novel mechanism by
which Plg induces recruitment of bone marrow (BM)–
derived stem cells to the infarcted heart, promoting cardiac
repair after MI. Moreover, our data reveal that Plg induces
C-X-C chemokine receptor type 4 (CXCR4) expression in
migrating BM stem cells and may contribute to stem cell
recruitment to the infarcted heart.
Methods
All animal procedures were performed in accordance
with protocols approved by the Institutional Animal Care
and Use Committee. The BM transplantation and induction
of MI, ﬂow cytometric analysis, histochemistry and immu-
nohistology of heart sections, Western blot of CXCR4
expression, zymography of matrix metalloproteinase-9
(MMP-9) activity, in vitro chemotaxis assay, and data
analysis are described in the Online Appendix.
Results
Plg is critical for G-CSF–stimulated cardiac function
recovery and tissue repair after infarction. G-CSF pro-
motes the recruitment of BM-derived stem cell to injured
tissue, leading to improvement of tissue repair and heart
function recovery in MI models (9,16–18). To investigatethe role of Plg in stem cell–
mediated tissue repair and heart
function recovery, MI was in-
duced in Plgþ/þ and Plg/mice
by ligation of the left anterior
descending coronary artery. Mice
were treated with G-CSF to
stimulate stem cell mobilization
from BM and recruitment to the
infarct heart, and cardiac func-
tion was analyzed by echocardi-
ography. Plg deﬁciency did not
alter normal heart function, as
indicated by the similar ejection
fraction of the left ventricle
(LV) observed in Plgþ/þ (86.7
 2.4%, n ¼ 6) and Plg/
(87.6  0.8%, n ¼ 8) mice
(Fig. 1A). The ligation sur-
gery induced inadequate cardiac
function, reducing LV ejection
fraction by about 50% in Plgþ/þ
and Plg/ mice (Fig. 1A). No
spontaneous recovery of heart
function was observed in the 28 days after MI surgery, as
shown by decreased ejection faction detected in Plgþ/þ and
Plg/ mice. Importantly, G-CSF signiﬁcantly increased
ejection fraction by one-half in Plgþ/þ, but not in Plg/
mice (Fig. 1A). Consistently, G-CSF reduced LV internal
diameter by approximately 30% to 40% in Plgþ/þ, but not
in Plg/ mice (Fig. 1B). These data indicate that Plg
is critical for G-CSF–stimulated heart function recovery
after MI.
We investigated the role of Plg in G-CSF–mediated
tissue repair after MI. G-CSF treatment signiﬁcantly
improved post-MI tissue repair in Plgþ/þ mice 4 weeks after
MI surgery, as evidenced by decreased infarct size by 30%
(Figs. 1C and 1D). In contrast, Plg/ mice had even
slightly larger infarct size, indicating that Plg is required for
G-CSF–stimulated tissue repair. Formation of new blood
vessels (i.e., neovascularization) is a fundamental process
during cardiac repair after MI. G-CSF induced a signiﬁcant,
2-fold increase in microvascular density in the infarcted area
in Plgþ/þ mice (Figs. 1E and 1F). Plg deﬁciency slightly
decreased basal neovascularization (without G-CSF treat-
ment), and completely abolished G-CSF–induced neovas-
cularization. Together, these data establish a critical role of
Plg in G-CSF–stimulated tissue repair and cardiac function
recovery after MI, implicating that Plg may promote stem
cell recruitment to improve cardiac repair and regeneration.
Plg is required for BM-derived stem cell recruitment in
the infarcted heart. G-CSF treatment is widely used to
enhance stem cell mobilization and recruitment to improve
cardiac repair after MI (9,18,19). Our previous work has
shown that Plg is required for G-CSF–induced stem cell
mobilization from BM to the circulation (20). To evaluate
Figure 1 Plg Is Required for G-CSF-Stimulated Heart Function Recovery After MI
(A to F) Myocardial infarction (MI) was induced in mice by ligation of the left anterior descending coronary artery, followed by treatment with or without granulocyte colony-
stimulating factor (G-CSF) for 5 days. (A and B) Heart function was evaluated by echocardiography before MI and 3 and 28 days after MI, and ejection fraction and left ventricular
(LV) interval diameter were measured. Data expressed as mean  SEM (n ¼ 5 to 8). (C to F) At 28 days after MI, heart tissue was harvested. (C and D) Heart sections were
stained with Masson’s trichrome dye. (C) Representative whole-heart images for serial sections. (D) Quantiﬁed data for infarct size (mean  SEM, n ¼ 5 to 6). (E and F)
Heart sections were subjected to immunoﬂuorescence analysis with anti-CD31 antibody. (E) Representative images. (F) Quantiﬁed data for vessel density (mean  SEM, n ¼ 4).
*p < 0.05. Plg ¼ plasminogen.
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2864the role of Plg in stem cell recruitment to the infarct heart
and cardiac repair after MI, we initially analyzed stem cell
mobilization after MI. An MI itself induced a moderate
stem cell mobilization, as indicated by a 2-fold increase in
cell number of stem cells (Linc-kitþ cells) detected by
ﬂuorescence-activated cell sorting (FACS) in circulation
in Plgþ/þ mice (Fig. 2A). G-CSF treatment robustly
promoted stem cell mobilization, with an 8-fold increase
in the number of stem cells in the blood of Plgþ/þ MI
mice. Plg deﬁciency almost completely inhibited MI-
induced stem cell mobilization and signiﬁcantly inhibitedG-CSF–stimulated mobilization, suggesting a necessary
role of Plg in stem cell mobilization in response to cardiac
infarction with or without G-CSF administration.
To track BM-derived stem cell recruitment in vivo
after MI, we performed BM transplantation to allow a visu-
alization of BM-derived green ﬂuorescent protein (GFPþ)
cells in the infarcted cardiac tissue (Fig. 2B). Immunoﬂuo-
rescence analysis showed that MI induced a mild recruit-
ment of BM-derived GFPþ cells and c-kitþ stem cells in
the infarct site, whereas G-CSF treatment induced marked
cell recruitment in Plgþ/þ mice (Fig. 2C). Importantly,
Figure 2 Plg Is Critical for Stem Cell Mobilization and Recruitment From BM to Infarcted Heart After MI
(A) At 5 days after MI surgery or sham operation with or without G-CSF injection, Lin–c-kitþ cells in blood were counted by ﬂuorescence-activated cell sorting (FACS) (mean 
SEM, n ¼ 6). *p < 0.05. (B) Scheme of experimental protocol. Bone marrow (BM) cells isolated from green ﬂuorescent protein (GFP) mice were transplanted into lethally
irradiated mice. An MI was induced, followed by different analyses. (C and D) At 10 days after MI surgery, heart tissue was harvested and subjected to immunoﬂuorescence
analysis with anti-GFP and anti–c-kit antibodies. Nuclei were stained with 40,6-diamidino-2-phenylindole. (C) Representative images. GFPþc-kitþ cells (yellow in merged pictures)
indicate BM-derived stem cells. (D) Graph represents the percentage of GFPþc-kitþ cells in infarct zone (mean  SEM, n ¼ 4 to 5). **p < 0.01. CXCR ¼ C-X-C chemokine
receptor type 4; other abbreviations as in Figure 1.
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Figure 3 Plg is Required for Neovascularization Mediated by BM Cell-Derived Cells
(A to D) GFPþ BM cells were transplanted to recipient mice, and MI was induced, followed by treatment with or without G-CSF. At 10 days after MI surgery, heart tissue was
harvested and immunohistochemically stained. (A) Heart sections were stained with anti-GFP and anti-CD31 antibodies. GFPþCD31þ cells indicate BM-derived endothelial cells
(yellow in merged pictures). (B) Heart sections were stained with anti-GFP and anti–a-vascular smooth muscle cell (SMC) actin antibodies. GFPþa-SMC actinþ cells indicate
BM-derived endothelial cells (yellow in merged pictures). (C and D) Graph represents the percentage of GFPþCD31þ and GFPþa-SMC actinþ cells in infarct zone (mean  SEM,
n ¼ 4 to 5). **p < 0.01. Abbreviations as in Figures 1 and 2.
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Figure 4 Plg Deﬁciency Inhibits CXCR4 Expression in Infarcted Cardiac Tissue and BM Cells
(A to D) An MI was induced in mice, followed by treatment with or without G-CSF. At 10 days after MI surgery, heart tissue was collected and immunohistochemically stained
with anti–SDF-1 (A and B) and anti-CXCR4 (C and D) antibodies. (A) Representative images for SDF-1 expression in infarct heart. (B) Graph represents SDF-1 expression level in
infarct heart (mean  SEM, n ¼ 4 to 5). (C) Representative images for CXCR4 expression in infarct heart. (D) Graph represents CXCR4 expression level in infarct heart (mean 
SEM, n ¼ 4 to 5). (E and F) An MI was induced, followed by treatment with or without G-CSF. At 5 days after MI surgery, BM cells were collected. (E) Cell lysate was resolved
by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed by immunoblot with anti-CXCR4 antibody. (F) The percentage of CXCR4þc-kitþ cells
was measured by FACS analysis (mean  SEM, n ¼ 7 to 9). *p < 0.05. **p < 0.01. NS ¼ no signiﬁcance; other abbreviations as in Figures 1 and 2.
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G-CSF–stimulated stem cell recruitment. Quantitative data
showed that Plg deﬁciency almost completely abolished
BM-derived GFPþc-kitþ stem cells after MI with or
without G-CSF treatment (Fig. 2D). Interestingly, Plg
deﬁciency had a much more profound effect on stem cell
recruitment (an 11-fold reduction, almost a reduction to
basal level) than cell mobilization (a 2-fold reduction),
suggesting a new, direct role of Plg in stem cell recruitmentand engraftment in addition to its known function in stem
cell mobilization.
Plg induces stemcell–mediatedneovascularizationafterMI.
Neovascularization is critical for cardiac repair and function
recovery after MI. Stem cells promote post-MI neo-
vascularization and tissue regeneration by differentiation to
new vascular cells, including endothelial cells (EC) and
vascular smooth muscle cells (SMC) (21). We investigated
the role of Plg in stem cell–mediated neovascularization.
Figure 5
Plg Induces CXCR4 Expression and Cell Migration
in BM Cells
(A and B) BMNCs were isolated from BM and treated with Plg for 40 hours. (A)
Cell lysate was analyzed by immunoblot with anti-CXCR4 antibody. (B) Cells
treated with or without Plg (10 mg/ml) were immunostained with anti-CXCR4
antibody, followed by FACS analysis. Inset: quantitative data for percentage of
CXCR4þ cells (C) Cell migration of BMNCs was induced in response to SDF-1 with
or without Plg (10 mg/ml) and AMD3100. Migrated cells were collected and
counted by hemocytometry, and subjected to FACS analysis. Data expressed as
mean  SEM (n ¼ 3). **p < 0.01.
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2868After BM transplantation with GFPþ BM cells and
MI induction, BM-derived cells, EC, and SMC were
visualized by immunoﬂuorescence with anti-GFP, -CD31,
and -a-SMC actin antibodies, respectively. Colocalization
analysis showed that over one-half of CD31þ and a-SMC
actinþ cells expressed GFP, conﬁrming their BM origin
and suggesting that BM-derived stem cells signiﬁcantlycontribute to newly generatedEC and SMC (Figs. 3A and 3B).
G-CSF substantially increased the cells number of BM-derived
EC and SMC, detected as GFPþCD31þ and GFPþa-SMC
actinþ cells, respectively (Figs. 3C and 3D), likely due to the
stimulation in stem cell recruitment. Plg deﬁciency inhibited
post-MI regeneration of EC and SMC by BM-derived
cells with or without G-CSF treatment, as indicated by
the remarkably diminished co-localization of GFPþCD31þ
and GFPþa-SMC actinþ cells in the infarct site of Plg/
mice. These data suggest that Plg is critical for stem
cell–mediated neovascularization, contributing to cardiac
repair after MI.
Plg promotes CXCR4 expression during stem cell
recruitment. Stromal cell-derived factor-1 (SDF-1)/
CXCR4 is the major chemoattractant ligand/receptor for
stem cell recruitment after MI (22–24). Immunohisto-
chemistry analysis showed that G-CSF induced robust
expression of both SDF-1 and CXCR4 in infarcted cardiac
tissue (Figs. 4A to 4D), consistent with their function
in enhancing stem cell mobilization and recruitment. To
explore the molecular mechanism of Plg in stem cell
recruitment, we investigated whether Plg regulates SDF-1/
CXCR4 expression. Plg did not affect SDF-1 expression
in infarcted heart tissue, as evidenced by the lack of a dif-
ference in SDF-1 expression detected in Plgþ/þ and Plg/
mice treated with or without G-CSF (Figs. 4A and 4B).
However, Plg deﬁciency signiﬁcantly inhibited CXCR4
expression in heart infarcts and abolished G-CSF–enhanced
CXCR4 expression (Figs. 4C and 4D), but did not affect basal
expression of CXCR4 in normal cardiac tissue without MI
(data not shown), suggesting that Plg is critical for CXCR4
expression in infarcted heart and particularly important forG-
CSF–stimulated CXCR4 expression. The reduced CXCR4
expression in heart infarcts in Plg/ mice may be due to a
decrease in the recruitment of CXCR4þ stem cells and/or a
decrease in the expression of CXCR4 in BM-derived stem
cells. To test the latter hypothesis, CXCR4 expression was
analyzed in the BM cells of Plgþ/þ and Plg/ mice who
received MI surgery and were treated with or without
G-CSF. Immunoblot analysis showed that MI surgery
induced CXCR4 expression in BM cells and that G-CSF
further increased its expression in Plgþ/þ mice (Fig. 4E),
consistent with their functions in promotion of stem cell
mobilization to circulation and recruitment in heart infarcts
(Fig. 2A), whereas basal expression of CXCR4 without
MI stress or G-CSF challenge was barely detectable in BM
cells of Plgþ/þ and Plg/ control mice (Fig. 4E). Plg deﬁ-
ciency completely abolished the CXCR4 expression in BM
cells, suggesting that Plg is necessary for MI-inducible,
G-CSF–stimulated CXCR4 expression. Similarly, FACS
analysis of BM c-kitþ stem cells showed that MI and G-CSF
up-regulated CXCR4 expression in BM stem cells of Plgþ/þ
mice, and Plg deﬁciency signiﬁcantly inhibitedMI-inducible,
G-CSF–stimulated CXCR4 expression in BM stem cells
(Fig. 4F). These data suggest that MI stress and G-CSF
challenge induce Plg-dependent CXCR4 expression in
Figure 6 CXCR4 Expression Is Required for Plg-Mediated Stem Cell Recruitment
(A to F) The BM cells isolated from GFP mice were transduced with lentivirus that expressed CXCR4 and were transplanted into lethally irradiated recipient mice. At 4 weeks
after transplantation, MI was induced, followed with G-CSF injection treatment (n ¼ 6). (A) Scheme of experimental protocol. (B) The BM cells were lentivirally transduced, and
cell lysate was immunoblotted with anti-CXCR4 and anti–b-actin antibodies. (C) At 10 days after MI, BM cells were isolated from BM transplantation recipient mice and
subjected to immunoblot analysis with anti-CXCR4 antibody. (D to F) At 10 days after MI, cardiac tissue was harvested and subjected to immunoﬂuorescence analysis with
anti-GFP and anti–c-kit antibodies. Nuclei were stained blue by 40,6-diamidino-2-phenylindole. (D) Representative whole-heart images for GFP.White dashed lines indicate infarct
area. (E) Representative images for BM-derived stem cells (GFPþc-kitþ, yellow in merged pictures) in infarcted area. (F) Graph represents the percentage of GFPþc-kitþ cells in
infarct zone (mean  SEM, n ¼ 4 to 5). **p < 0.01. Abbreviations as in Figures 1 and 2.
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Figure 7 Plg-Mediated CXCR4 Expression and Stem Cell Migration Depends on MMP-9 Activation
(A and B) An MI was induced in mice, followed by treatment with or without G-CSF for 5 days. Protease activity in blood plasma was analyzed by gelatin zymography, and the
proenzyme and active forms of MMP-9 were identiﬁed by molecular weight relative to markers. (A) Representative images. (B) Quantitative data of the intensity of MMP-9 bands
are shown (mean  SEM, n ¼ 3). (C) Bone marrow mononuclear cells (BMNCs) were treated with Plg (10 mg/ml) for 40 h. Cell culture medium was collected and subjected to
gelatin zymography analysis. (D) Cell migration in BMNCs was induced by SDF-1 in the presence or absence of Plg with control immunoglobulin (Ig)G and MMP-9 antibody. Cell
number of migrated BMNCs was counted (mean  SEM, n ¼ 3). (E) The BMNCs were treated with Plg in the presence of control IgG or MMP-9 neutralizing antibody and were
subjected to FACS analysis with anti-CXCR4 antibody. Inset: quantitative data for percentage of CXCR4þ cells. *p < 0.05. **p < 0.01. Abbreviations as in Figures 1 and 2.
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2870BM-derived stem cells, leading to stem cell recruitment to
infarct site and cardiac repair after MI.
Plg induces cell migration by up-regulating CXCR4
expression in BM-derived cells. To test whether Plg
directly regulates CXCR4 expression in BM cells, bone
marrow mononuclear cells (BMNCs) were isolated and
treated with Plg in vitro. Immunoblot analysis showed
that Plg induced CXCR4 expression in BMNCs in a dose-
dependent manner (Fig. 5A). FACS analysis conﬁrmed a
2-fold up-regulation in CXCR4 expression induced by
2 mg/ml Plg (Fig. 5B).We further investigated whether
CXCR4 is critical for Plg-mediated stem cell migration.
BMNC migration was induced by SDF-1 chemotaxis in
the presence or absence of AMD3100, a CXCR4 antago-
nist that inhibits CXCR4 binding to SDF-1 and blocks
CXCR4 function. Plg signiﬁcantly increased cell migration of
total BM cells and Linc-kitþ stem cell migration in response
to SDF-1 (Fig. 5C), as determined by counting migrated
BMNCs by hemocytometry and Linckitþ stem cells by
FACS (Fig. 5C). Importantly, AMD3100 signiﬁcantly
inhibited Plg-stimulated BM cell migration and completed
abolished Plg-mediated Linckitþ stem cell migration,
indicating that CXCR4 is required for Plg-stimulated cellmigration in BM cells, particularly in BM-derived stem
cells.
CXCR4 is required for Plg-mediated BM-derived stem
cell recruitment to the infarct site after MI. To investi-
gate the role of CXCR4 in Plg-mediated stem cell
recruitment after MI, we tested whether CXCR4 over-
expression rescues the diminished stem cell recruitment
induced by Plg deﬁciency (Fig. 6A). GFPþ BM cells were
lentivirally transduced to overexpress CXCR4, as indicated
by the 2-fold higher expression at the protein level
(Fig. 6B). The transduced BM cells were transplanted
to lethally radiated Plgþ/þ and Plg/ recipient mice,
which efﬁciently restored CXCR4 expression in BM cells
in Plg/ mice (Fig. 6C). Mice were subjected to MI
induction and G-CSF challenge. Immunoﬂuorescence
analysis showed that restoration of CXCR4 expression
efﬁciently rescued the recruitment of BM-derived cells
(GFPþ cells) in infarcted heart tissue of Plg/ mice
(Fig. 6D). Similarly, recruitment of BM-derived stem
cells, detected as GFPþc-kitþ cells, was signiﬁcantly
enhanced by the CXCR4 overexpression in Plg/ mice
(Figs. 6E and 6F), suggesting that CXCR4 is critical for
Plg-mediated stem cell recruitment after MI.
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2871Plg-mediated CXCR4 expression depends on MMP-9
activation. Matrix metalloproteinases, including MMP-3,
-9, and -13, serve as downstream targets of plasmin activ-
ity (25,26), which may be involved in Plg-mediated stem cell
recruitment. Zymography assay showed that no detectable
MMP-9 activation was observed in the BM of Plgþ/þ or
Plg/ mice before MI surgery (data not shown); however,
MI induced remarkable MMP-9 activation in the BM of
Plg/ mice, which was further increased by G-CSF treat-
ment (Figs. 7A and 7B). Importantly, Plg deﬁciency signif-
icantly attenuated the MMP-9 activation induced by MI
with or without G-CSF challenge, suggesting that Plg in-
duces MMP-9 activation in BM cells after MI. Consistently,
Plg treatment in vitro with BMNCs isolated from BM cells
induced MMP-9 activation (Fig. 7C). To test whether
MMP-9 activation is required for Plg-mediated cell migra-
tion, BMNCs were induced to migrate in response to SDF-1
in the presence of Plg. MMP-9 activation was blocked by
adding a neutralizing antibody, which efﬁciently abolished
MMP-9 activity, as previously shown (25). MMP-9 neutrali-
zation inhibited the Plg-induced cell migration in response to
SDF-1 in BMNCs (data not shown) and Linc-kitþ stem
cells (Fig. 7D), indicating that MMP-9 is essential for Plg-
mediated stem cell migration. We also tested the role of
MMP-9 in Plg-mediated CXCR4 expression. MMP-9
neutralizing antibody signiﬁcantly inhibited Plg-regulated
CXCR4 expression (Fig. 7D). These results suggest that
MMP-9 may serve as a mediator for Plg-mediated CXCR4
expression and stem cell recruitment after MI.
Discussion
Despite many breakthroughs in cardiovascular medicine, MI
remains a major cause of mortality in the United States. Stem
cell recruitment and differentiation to mature cells, includ-
ing cardiomyocytes and vascular cells, to replace injured car-
diac tissue is a key repair process after MI. Our study
elucidates a Plg-mediated molecular mechanism regulating
stem cell recruitment and cardiac repair after MI. CXCR4
is a major chemotactic receptor for stem cell migration,
which is critical for stem cell mobilization and recruitment.
Here, we reveal an important mechanism for up-regulation
of CXCR4 expression, leading to stem cell recruitment
and tissue repair. These ﬁndings will contribute to the
development of new therapeutic strategies (e.g., targeting
Plg/MMP-9) for strengthening stem cell therapy for sole
or G-CSF–combined MI treatment.
In addition to its canonical, antithrombosis function, Plg
is critical for tissue repair after MI, wound healing, and
liver injury (13–15,27,28). Notably, deﬁciency of urokinase
Plg activator completely protected against rupture but im-
paired scar formation and infarct revascularization, whereas
Plg deﬁciency abolished inﬂammatory cell inﬁltration and
necrotic cardiomyocyte removal, suggesting that the Plg
system is required for the cardiac repair after MI (13,29).
Recent studies have also shown that Plg is critical for stemcell mobilization after 5-ﬂuoruracil–induced myelosup-
pression and G-CSF challenge (30–33). Here, for the ﬁrst
time to our knowledge, we demonstrate that Plg regulates
stem cell homing to the infarcted heart and contributes to
cardiac repair after MI.
SDF-1/CXCR4 is a critical chemotaxis pathway for stem
cell mobilization and recruitment after MI (22–24,34).
Upon injury, CXCR4 expression is induced in the stem
cells, and CXCR4þ stem cells are recruited from BM to the
lesion in response to SDF-1 that is overexpressed in the
lesion, which is critical for cardiac repair after MI. Based
on this function, several therapeutic strategies have been
developed to enhance stem cell–mediated tissue repair,
including local SDF-1 delivery and inhibition of SDF-1
cleavage, pharmacological mobilization of CXCR4þ cells
from BM, and genetic up-regulation of CXCR4 expression
in BM-derived stem cells (35,36). The mechanism under-
lying regulation of SDF-1/CXCR4 signals during stem cell
recruitment has not been fully understood. Here, we show
that Plg contributes importantly to regulation of CXCR4
expression in recruiting stem cells after MI. CXCR4 ex-
pression is subject to transcriptional regulation as well as
receptor desensitization and degradation by multiple signals
including calcium, cAMP, PKA, and PKC (37). Whether
and how Plg regulates these signals remain unclear.
MMP-9 serves as a common downstream signal for Plg to
regulate inﬂammatory cell migration in many pathological
processes, including aneurysm formation and atherosclerosis
development (25,38,39). Here, we reveal that MMP-9 is
required for Plg-mediated CXCR4 expression in stem cells
during cardiac repair afterMI.Consistently, a recent study has
shown that CXCR4 is critical for MMP-9–mediated stem
cell migration, as evidenced by G-CSF stimulation ofMMP-
9 activity in BM cells, but no stem cell mobilization in
CXCR4/ mice, and by the fact that transplantation of
CXCR4þVEGFR2þ cells into MMP-9/mice rescues the
impaired ischemic revascularization (40,41). Our ﬁndings
provide the direct evidence that Plg-dependent MMP-9
activation regulates CXCR4 expression for stem cell recruit-
ment. Several possible mechanisms may contribute to this
process, including Plg/MMP-9–mediated up-regulation of
CXCR4 messenger ribonucleic acid expression by activation
of intracellular signals or autocrine/paracrine effects by stim-
ulated growth factors and cytokines, and protease-inducible
inhibition of CXCR4 desensitization and degradation.
Conclusions
We elucidate a distinct mechanism underlying stem cell–
mediated cardiac repair after MI. In this newly identiﬁed
pathway, Plg regulates CXCR4 expression in BM-derived
stem cells by activating MMP-9, particularly in the setting
of G-CSF challenge, to induce cell homing to the lesion,
promoting cardiac repair after MI. Thus, targeting Plg
may offer a therapeutic opportunity to enhance stem cell–
mediated cardiac repair after MI.
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